Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Gregory Fraser is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/24/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
07/25/2024 | BHC | Buy Now | Bausch Health Companies | $5.88 | 19.05% | $8 → $7 | Maintains | Hold | Get Alert |
04/30/2024 | XAIR | Buy Now | Beyond Air | $0.58 | 1281.69% | $10 → $8 | Maintains | Buy | Get Alert |
03/01/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $62.03 | 28.97% | $72 → $80 | Maintains | Buy | Get Alert |
02/16/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $62.03 | 16.07% | $70 → $72 | Maintains | Buy | Get Alert |
01/18/2024 | BTMD | Buy Now | Biote | $7.87 | 14.36% | $10 → $9 | Maintains | Buy | Get Alert |
11/14/2023 | XAIR | Buy Now | Beyond Air | $0.58 | 1627.12% | $14 → $10 | Maintains | Buy | Get Alert |
11/08/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $7.38 | -5.15% | $6 → $7 | Maintains | Buy | Get Alert |
09/06/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $7.38 | -18.7% | → $6 | Reiterates | Buy → Buy | Get Alert |
08/21/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $62.03 | 12.85% | → $70 | Reiterates | Buy → Buy | Get Alert |
08/07/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $7.38 | -18.7% | $4 → $6 | Maintains | Buy | Get Alert |
08/03/2023 | CORT | Buy Now | Corcept Therapeutics | $34.87 | -16.83% | $26 → $29 | Maintains | Hold | Get Alert |
07/21/2023 | XAIR | Buy Now | Beyond Air | $0.58 | 2317.96% | $18 → $14 | Maintains | Buy | Get Alert |
07/21/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $62.03 | -3.27% | $52 → $60 | Maintains | Buy | Get Alert |
06/06/2023 | NVCR | Buy Now | NovoCure | $18.65 | 409.38% | → $95 | Reiterates | Buy → Buy | Get Alert |
05/26/2023 | EOLS | Buy Now | Evolus | $12.13 | 48.39% | $14 → $18 | Maintains | Buy | Get Alert |
05/26/2023 | CORT | Buy Now | Corcept Therapeutics | $34.87 | -25.44% | $28 → $26 | Maintains | Hold | Get Alert |
05/26/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.10 | 296.04% | $45 → $40 | Maintains | Buy | Get Alert |
05/09/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $62.03 | -16.17% | $50 → $52 | Maintains | Buy | Get Alert |
03/29/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $7.38 | -45.8% | $5 → $4 | Maintains | Buy | Get Alert |
03/29/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.10 | 345.54% | $50 → $45 | Maintains | Buy | Get Alert |
11/08/2022 | CORT | Buy Now | Corcept Therapeutics | $34.87 | -19.7% | $30 → $28 | Maintains | Hold | Get Alert |
10/28/2022 | NVCR | Buy Now | NovoCure | $18.65 | 446.92% | $105 → $102 | Maintains | Buy | Get Alert |
09/27/2022 | BTMD | Buy Now | Biote | $7.87 | 27.06% | → $10 | Initiates | → Buy | Get Alert |
08/24/2022 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | — | Downgrade | Buy → Hold | Get Alert |
08/01/2022 | CORT | Buy Now | Corcept Therapeutics | $34.87 | -13.97% | → $30 | Downgrade | Buy → Hold | Get Alert |
07/29/2022 | NVCR | Buy Now | NovoCure | $18.65 | 463% | $118 → $105 | Maintains | Buy | Get Alert |
07/29/2022 | BHC | Buy Now | Bausch Health Companies | $5.88 | — | — | Downgrade | Buy → Hold | Get Alert |
06/29/2022 | XAIR | Buy Now | Beyond Air | $0.58 | 3354.23% | $16 → $20 | Maintains | Buy | Get Alert |
05/17/2022 | CRXT | Buy Now | Clarus Therapeutics Hldgs | — | — | $7 → $3 | Maintains | Buy | Get Alert |
04/14/2022 | ATRS | Buy Now | Antares Pharma | — | — | $7 → $5.6 | Downgrade | Buy → Hold | Get Alert |
01/28/2022 | CORT | Buy Now | Corcept Therapeutics | $34.87 | -13.97% | → $30 | Initiates | → Buy | Get Alert |
01/20/2022 | EOLS | Buy Now | Evolus | $12.13 | -9.32% | → $11 | Upgrade | Hold → Buy | Get Alert |
11/12/2021 | XAIR | Buy Now | Beyond Air | $0.58 | 2663.39% | — | Maintains | Buy | Get Alert |